Zobrazeno 31 - 40
of 151
pro vyhledávání: '"Onno W. Akkerman"'
Autor:
Samiksha Ghimire, Deni Iskandar, Roelina van der Borg-Boekhout, Marina Zenina, Mathieu S. Bolhuis, Huib A.M. Kerstjens, Marieke van Rossum, Daan J. Touw, Tanja R. Zijp, Job F.M. van Boven, Onno W. Akkerman
Publikováno v:
European Respiratory Journal, 60:2201690. EUROPEAN RESPIRATORY SOC JOURNALS LTD
Tuberculosis (TB) is the world-leading cause of infectious disease related mortality, apart from COVID-19 presently [1]. Standard TB treatment for drug-susceptible (DS) TB takes 6–9 months and requires daily intake of multiple medications [1]. Nota
Autor:
Jan-Willem C. Alffenaar, Ivan S. Pradipta, Natasha van't Boveneind-Vrubleuskaya, Onno W. Akkerman, Eelko Hak
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 8, Iss 1, Pp 1-12 (2019)
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, 8:115. BioMed Central Ltd.
Antimicrobial Resistance and Infection Control
Antimicrobial Resistance and Infection Control, 8:115. BioMed Central Ltd.
Background Since in low incidence TB countries population migration and complex treatment of drug-resistant tuberculosis (DR-TB) patients are major issues, we aimed to analyse patient risk factors associated with the incidence of poor outcome of TB t
Autor:
Hannah Yejin Kim, Xavier Padanilam, Jin-Gun Cho, Barbara Seaworth, Jan-Willem C. Alffenaar, Onno W. Akkerman
Publikováno v:
Essential Tuberculosis ISBN: 9783030667054
Anti-tuberculosis (TB) drugs can cause adverse drug reactions, particularly the older second-line drugs. Early intervention and adequate management of adverse drug reactions are important to prevent complications. Laboratory testing at baseline and d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6404bd1fceef7737adbb4911c7474f98
https://doi.org/10.1007/978-3-030-66703-0_13
https://doi.org/10.1007/978-3-030-66703-0_13
Autor:
Tjip S. van der Werf, Onno W. Akkerman
Publikováno v:
Essential Tuberculosis ISBN: 9783030667054
Increasing complexity of tuberculosis (TB) is one of the causes that TB is still the leading cause of death by an infectious disease. Among the complicating factors are increasing drug resistance and comorbidities. Patient-centred care, and even more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11e1d3d7d4a370ec3b8345de1a7aa2d3
https://doi.org/10.1007/978-3-030-66703-0_20
https://doi.org/10.1007/978-3-030-66703-0_20
Autor:
Huib A. M. Kerstjens, Mathieu S. Bolhuis, Hendrik W. Frijlink, Marieke G G Sturkenboom, Paul Hagedoorn, I. Sibum, Floris Grasmeijer, Y.A. de Reus, Onno W. Akkerman
RationaleInhaled antimicrobials enable high local concentrations where needed and, compared to orally administration, greatly reduce the potential for systemic side effects. In SARS-CoV-2 infections, hydroxychloroquine (HCQ) administered as dry powde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::316c1d5615c6d8d73ade350c831cd87f
https://doi.org/10.1101/2020.12.03.20243162
https://doi.org/10.1101/2020.12.03.20243162
Publikováno v:
International Journal of Tuberculosis and Lung Disease, 25(6), 419-420. International Union against Tubercul. and Lung Dis.
The International Journal of Tuberculosis and Lung Disease
The International Journal of Tuberculosis and Lung Disease
SUMMARY BACKGROUND: There are no data comparing the 6–9 month oral three-drug Nix regimen (bedaquiline, pretomanid and linezolid [BPaL]) to conventional regimens containing bedaquiline (B, BDQ) and linezolid (L, LZD). METHODS: Six-month post end-of
Autor:
Onno W. Akkerman, Mireille A. Wessels, Samiksha Ghimire, Daan J Touw, Jan-Willem C. Alffenaar, Erwin M Jongedijk, Simone H J van den Elsen, Mathieu S. Bolhuis, Tjip S. van der Werf
Publikováno v:
European Respiratory Journal, 56(4):2000803. EUROPEAN RESPIRATORY SOC JOURNALS LTD
The persisting worldwide burden of tuberculosis (TB) is worrisome. In 2018, an estimated 10 million individuals developed TB and 1.45 million deceased [1]. The increase in drug resistance is an important point of concern. Resistance can be acquired b
Autor:
Bart L. Rottier, Henderik W. Frijlink, Gerard H. Koppelman, Onno W. Akkerman, Judith M. Vonk, Paul Hagedoorn, A M Akkerman-Nijland, H. van der Vaart, Huib A. M. Kerstjens, Floris Grasmeijer
Publikováno v:
PLoS ONE, Vol 15, Iss 9, p e0239658 (2020)
PLoS ONE, 15(9):e0239658. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, 15(9):e0239658. PUBLIC LIBRARY SCIENCE
PLoS ONE
BACKGROUND: Nebulization of antimicrobial drugs such as tobramycin and colistin is a cornerstone in the treatment of patients with cystic fibrosis (CF) infected with Pseudomonas aeruginosa. However, nebulization has a high treatment burden. The Twinc
Autor:
J F M van Boven, Fajri Gafar, Ivan S. Pradipta, Onno W. Akkerman, J-W C Alffenaar, Eelko Hak, R A Chimeh
Publikováno v:
International Journal of Tuberculosis and Lung Disease, 24(8), 811-819. International Union against Tubercul. and Lung Dis.
BACKGROUND: Despite considerable efforts to globally eradicate TB, and the availability of effective antibiotics, TB elimination goals are falling behind. While non-adherence to TB drug regimens may compromise effective treatment, its full impact is
Autor:
H. Zondag, W C M de Lange, T S van der Werf, Huib A. M. Kerstjens, M. P. Schultink, L. ter Beek, R. Brijan, Onno W. Akkerman
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 24(5)